- Home
- KEN vs LIVN Comparison
KEN vs LIVN Comparison
Compare KEN & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEN
- LIVN
- Stock Information
- Founded
- KEN 2014
- LIVN 1987
- Country
- KEN Singapore
- LIVN United Kingdom
- Employees
- KEN N/A
- LIVN N/A
- Industry
- KEN Electric Utilities: Central
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KEN Utilities
- LIVN Health Care
- Exchange
- KEN Nasdaq
- LIVN Nasdaq
- Market Cap
- KEN 2.2B
- LIVN 2.1B
- IPO Year
- KEN N/A
- LIVN 1993
- Fundamental
- Price
- KEN $44.77
- LIVN $46.21
- Analyst Decision
- KEN
- LIVN Strong Buy
- Analyst Count
- KEN 0
- LIVN 7
- Target Price
- KEN N/A
- LIVN $59.29
- AVG Volume (30 Days)
- KEN 23.0K
- LIVN 543.9K
- Earning Date
- KEN 05-28-2025
- LIVN 07-30-2025
- Dividend Yield
- KEN 10.95%
- LIVN N/A
- EPS Growth
- KEN N/A
- LIVN N/A
- EPS
- KEN 11.35
- LIVN N/A
- Revenue
- KEN $760,304,000.00
- LIVN $1,275,380,000.00
- Revenue This Year
- KEN N/A
- LIVN $8.10
- Revenue Next Year
- KEN N/A
- LIVN $5.76
- P/E Ratio
- KEN $3.83
- LIVN N/A
- Revenue Growth
- KEN 5.78
- LIVN 7.62
- 52 Week Low
- KEN $23.31
- LIVN $32.48
- 52 Week High
- KEN $44.63
- LIVN $57.35
- Technical
- Relative Strength Index (RSI)
- KEN 85.03
- LIVN 57.98
- Support Level
- KEN $42.20
- LIVN $45.20
- Resistance Level
- KEN $39.69
- LIVN $46.50
- Average True Range (ATR)
- KEN 0.72
- LIVN 1.20
- MACD
- KEN 0.55
- LIVN -0.14
- Stochastic Oscillator
- KEN 99.16
- LIVN 75.60
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.